Author: Zimmerling, Amanda; Chen, Xiongbiao
Title: Bioprinting for combating infectious diseases Cord-id: vf77fva9 Document date: 2020_9_28
ID: vf77fva9
Snippet: Infectious diseases have the ability to impact health on a global scale, as is being demonstrated by the current coronavirus disease 2019 (COVID-19) pandemic. The strenuous circumstances related to this global health crises have been highlighting the challenges faced by the biomedical field in combating infectious diseases. Notably, printing technologies have advanced rapidly over the last decades, allowing for incorporating living cells in the printing process (or bioprinting) to create constru
Document: Infectious diseases have the ability to impact health on a global scale, as is being demonstrated by the current coronavirus disease 2019 (COVID-19) pandemic. The strenuous circumstances related to this global health crises have been highlighting the challenges faced by the biomedical field in combating infectious diseases. Notably, printing technologies have advanced rapidly over the last decades, allowing for incorporating living cells in the printing process (or bioprinting) to create constructs that are able to serve as in vitro tissue or virus-disease models in combating infectious diseases. This paper describes applications of bioprinting in addressing the challenges faced in combating infectious diseases, with a specific focus on in vitro modelling and on development of therapeutic agents and vaccines. Integration of these technologies may allow for a more efficient and effective response to current and future pandemics.
Search related documents:
Co phrase search for related documents- active pharmaceutical ingredient and magnetic resonance: 1
- acute ards respiratory distress syndrome and administered drug: 1
- acute ards respiratory distress syndrome and liver tissue: 1, 2, 3
- acute ards respiratory distress syndrome and living cell: 1
- acute ards respiratory distress syndrome and long term immune memory: 1
- acute ards respiratory distress syndrome and long term maintenance: 1
- acute ards respiratory distress syndrome and lung model: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44
- acute ards respiratory distress syndrome and lung model infection: 1
- acute ards respiratory distress syndrome and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- acute ards respiratory distress syndrome and lung tissue model: 1, 2, 3, 4, 5, 6
- acute ards respiratory distress syndrome and magnetic resonance: 1, 2, 3, 4, 5, 6
- acute ards respiratory distress syndrome lead and lung tissue: 1
- acute ards respiratory distress syndrome lead and magnetic resonance: 1
Co phrase search for related documents, hyperlinks ordered by date